Biolinq
Pre-clinicalBiolinq ShineTM is the first glucose sensor with no hypodermic needle for insertion, integrating glucose, activity, and sleep information in a single device. A simple user experience delivers a new level of engagement in glucose monitoring.
Founded
2012
Focus
Medical DevicesDiagnosticsDigital Health
About
Biolinq ShineTM is the first glucose sensor with no hypodermic needle for insertion, integrating glucose, activity, and sleep information in a single device. A simple user experience delivers a new level of engagement in glucose monitoring.
Funding History
2Total raised: $113M
Series B$100MRiverVest Venture PartnersJun 15, 2022
Series A$13MAlpha EdisonMar 15, 2021
Company Info
TypePrivate
Founded2012
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile